The novel coronavirus, SARS-CoV-2, and the associated Corona Virus Disease (COVID-19), described in Wuhan, China in December 2019, resulted in a global health emergency [1] [2]. Many countries in sub-Saharan Africa (SSA) including Uganda, in compliance with World Health Organization (WHO) recommendations [1], first instituted strict lockdown measures on 18^th March 2020, as part of the COVID-19 containment measures [3] [4]. These measures included closure of all educational institutions, transport restrictions with total ban on public means of transport and closure of all places that encourage crowding [1] [5]. While the lockdowns aimed at limiting community spread of COVID-19, it also resulted in untold consequences, such as reduced access to medical services including those of HIV, which could negatively influence treatment outcomes [4]. With a fragile healthcare system often constrained by inadequate human resources and logistics, COVID-19 was feared to undermine progress in ending the HIV epidemic in many developing countries such as those in SSA [6]. Moreover, the diversion of healthcare resources to manage COVID-19 patients [7] and the lockdown measures were predicted to further negatively impact HIV service access and utilization. Furthermore, the adverse psychosocial and socioeconomic situations caused by loss of employment and direct impact of COVID-19 [8] could further increase chances of PLHIV missing their scheduled clinic appointments; hence, interrupting treatment. Home to about 66.7% of global population of people living with HIV (PLHIV) [9], SSA was expected to suffer worst, from the direct and indirect effects of COVID-19 [3] [4]. The effect of HIV care and treatment disruption could lead to increased adverse service outcomes, such as morbidity and mortality among the PLHIV.

Indeed, modeling studies have predicted increased morbidity and death from AIDS-related illnesses in the region [6] [10]. For example, a five-year effect of HIV treatment interruption is predicted to cause 10% increment in AIDS-related deaths [10] [11]. Similarly, a separate study indicated that a six-month interruption in HIV treatment could cause 1.63 times increase in death in one year [6]. The realization of this chilling prediction could stifle great gains in the HIV fight that have been achieved in SSA, including Uganda. In the case of Uganda, AIDS related mortality had reduced by 58% by the end of 2019 compared to the 2010 figures [12]. Besides, 87% of PLHIV in Uganda knew their status, with 84% on treatment and 75% achieving viral suppression by the end of December 2019, which was in line with the global targets of 95-95-95 [12] [13]. It is critical for these gains to be sustained and propelled forwards to realize the global targets of epidemic control. However, for the country to sustain this momentum, PLHIV need to remain in care and on ART without substantial interruptions which may ensure optimal adherence with subsequent viral load suppression [8] [14]. Unfortunately, the COVID-19 pandemic has directly or indirectly caused massive disruptions in HIV services in the country, leading to limited access to antiretroviral therapy (ART) to PLHIV [8]. This may peg back the national and sub-national progress in the race to attain the AIDS epidemic control by 2030 [15].

The international community acknowledges this disturbing fact and has encouraged different countries to innovate strategies that may mitigate its effects [16] [17]. However, for Uganda to effectively circumvent the potential catastrophe posed by the disruptions in HIV services, there is need to appreciate the actual burden of HIV treatment interruptions in the country. To date, there is only a paucity of data indicating the actual burden of HIV treatment interruptions in Uganda following the COVID-19 pandemic, which may frustrate development of appropriate policies to respond to the COVID-19 devastation in HIV services. In consequence, our paper provides evidence on the burden of disengagement of PLHIV in care at The AIDS Support Organization (TASO) Mbale clinic in Eastern Uganda during the April-June 2020 quarter, the COVID-19 Pandemic peak period in Uganda. This will contribute to the existing body of knowledge to guide policy in the implementation of client-centered HIV care services in response to calls by UNAIDS and WHO for governments to develop context specific COVID-19 counter measures.

As demonstrated in Table 1, a total of 6744 patients scheduled for clinical services at TASO Mbale CoE during the quarter of April to June 2020, 4647 (68.9%) were females and 2097 (31.1%) males. In terms of service point, 4220 (62.6%) were scheduled to access their comprehensive HIV services from the community while 2524 (37.4%) were supposed to be reviewed at the facility. The vast majority of our patients were adults (5982, 88.7%) aged 25 years or older while the children, adolescents and the youths constituted 2%, 5.9% and 3.4% respectively.

Out of the 6744 patients on scheduled appointment during the quarter, 1710 (25.3%) patients missed their appointment including 1160 (67.8%) females and 550 (32.2%) males. Importantly, more patients 960 (56.1%) missed at the facility than in the community (750, 43.9%). Comparatively, in the quarter of January to March 2020, out of 7279 patients on scheduled appointment, only 519 missed their appointments, translating to 7.1%. Multi-month drug refills were strongly associated with missed appointment (P-value < 0.001).

From Table 2, 337 (19.7%) patients were followed and provided with services while 18 (1.1%) deaths were recorded and 7 clients were transferred out to other facilities during this period. Majority of the patients (1348, 78.8%) were yet to be followed up and statuses determined.

From Table 3, it can be seen that age group is associated with missed appointment (P-value < 0.001) and service point (P-value < 0.001) while sex was not associated with missed appointment (P-value = 0.269). Moreover, it was found that individuals with an up-to-date viral load result (within 12 months before study period) were less likely to miss their appointment compared to those without (P < 0.001).

From Table 4, the columns of results of the unadjusted ratios show that age group, service point, viral load status and multi-months drug dispensing respectively were statistically significant (P < 0.05) in influencing missed appointments. Specifically, the youths (20 - 24 years) were 2.13 times more likely to miss appointments as compared to children (0 - 9 years) (OR = 2.13; 95% C. I [1.3111 - 3.4636]; P < 0.001). Relatedly, PLHIV receiving ART services from facility arm

*Significant (P < 0.05).

*Significant (P < 0.05).

were 2.84 times more likely to miss their scheduled appointments compared to their counterparts in the community (OR = 2.84; 95% [2.5374 - 3.1785] P < 0.001). As regards their viral load status in the last 12 months, results also depicted that clients with suppressed viral load in the past 12 months were 73% less likely to miss their appointments as compared to those who had never been bled for viral load (OR = 0.73; 95% C.I [0.2328 - 0.3125]); P < 0.001). Additionally, clients with unsuppressed VL in the past 12 months were 51% less likely to miss their scheduled appointments as compared to their counterparts who have never been monitored for VL in the last 12 months (OR = 0.51; C.I [0.3792 - 0.6377] P < 0.001). In the same vein, clients who received ART for one month, two months and three months, respectively were three or more times more likely to miss their scheduled appointments compared to those who received ART for 6 or more months (OR = 6.36, 5.29, 3.44; 95% C.I [4.8410 - 8.3617]; [4.0506 - 6.9072]; [3.0397 - 3.9012] P < 0.001). On the contrary, sex was found to be insignificant in influencing missed appointments (P > 0.05).

Further, the multivariate results from the columns of the adjusted odds ratios suggest that age group, service point and VL status are statistically significant influencers of missed appointments (P < 0.05). Precisely, adults aged 25 years and above were 2.79 times more likely to miss their scheduled appointments as compared to children less than 10 years of age (OR = 2.79, 95% CI [1.8181 - 4.2724]; P < 0.001). The youths were 2.42 times more likely to miss their scheduled appointments as compared to the children less than 10 years of age (OR = 2.42; 95% C.I [1.4663 - 3.9975]; P < 0.001). Moreover, the adjusted ratios consistently suggest that clients receiving their ART care services from the facility were 1.82 times more likely to miss their scheduled visits as compared to their colleagues receiving treatment from the community arm (OR = 1.82; 95% C.I [1.5872 - 2.0943] P < 0.001). As per the VL status, clients with suppressed VL in the last 12 months were 58% less likely to miss their appointments as compared to their counterparts without any VL results in the past 12 months (OR = 0.58; 95% C.I [0.3593 - 0.4949] P < 0.001). Furthermore, those with unsuppressed VL results in the past 12 months were 46% less likely to miss their scheduled appointments when compared to their colleagues who were not bled for VL in the last 12 months (OR = 0.46; 95% C.I [0.4105 - 0.7181] P < 0.001). The results also showed that clients who received ART for one month, two months and three months, respectively were two or more times more likely to miss their scheduled appointments compared to those who received ART for 6 or more months (OR = 2; 95 C.I [2.7916 - 5.1218]; [3.1609 - 5.7094]; [2.4289 - 3.2048] P < 0.001). Therefore, six-month refills could potentially provide for continued engagement of PLHIV in care. At multivariate level, sex was not a significant influencer of missed appointments in the period of study, which is consistent with previous results from chi-square and unadjusted ratios (P > 0.05)

In this study, we found that 1710 (25.3%) out of 6744 PLHIV on scheduled appointment during the April-June 2020 quarter missed their clinic encounters at TASO Mbale clinic compared to just 7.1% during the preceding quarter of January-March 2020. The PLHIV most likely to miss their clinic encounters were those without an up-to-date viral load test done in the previous twelve months before the period (P < 0.05), those who were in the facility model of treatment compared to those served through the community arms (P < 0.001), youths aged 20 - 24 years compared to other age groups (P < 0.001), and those who received less than 6 months of drugs at their last clinic visit (P < 0.001). There were no significant gender differences observed. Overall, there was a 356% increment in the missed appointment rate compared with the 7.1% (519/7279) experienced during the January-March 2020 quarter.

High rate of missed appointment among the PLHIV during this quarter could be attributed to increased clinical, psychological and structural barriers to accessing HIV treatment services, such as increased transport costs and transport lockdown restrictions, and perceived risk of increased COVID-19 exposure from health facilities as was described by Nalubega et al. and Linnemayr et al. [23] [24]. Our finding is supported by a Chinese study that indicated that 32.6% of PLHIV could potentially miss their drugs and 48.6% were unsure of where or how to access the much-needed lifesaving ART during the lockdown [3]. Another study in the United States of America (US) reported rescheduling 30% of the 98 PLHIV on appointment during the first four weeks (March 21-April 17) of the COVID-19 peak in Chicago [25]. Furthermore, many HIV clinics reduced working hours to beat the curfew imposed by the Government of Uganda which further curtailed access to ART related services [7]. In addition, some key health workers were absorbed into the COVID-19 task force while others worked from home; thus, limiting service provision [7]. In TASO Mbale, like other health facilities in Uganda at the time, volunteers and students on academic placement in the facility were all asked to stay home. This resulted in further increased workload on the already limited available workforce. Importantly, domestic violence cases spiked during the lockdown restrictions with women living with HIV disproportionately affected and this further hampered their abilities to access HIV care services. For example, in South Africa, 67000 cases of domestic violence were reported in the first week of the COVID-19 lockdown [26].

Relatedly, this study revealed that facility-based clients were more likely to miss their appointment than their community-based counterparts; hence, suffering greater treatment interruption. From the study results, it can be concluded that the transport restrictions could have contributed significantly to this situation because TASO Mbale clinic provides services to individuals as far away from the facility as 75 km. In addition, it was perhaps easier to mobilize clients in their community groups using telephone calls directly to individual clients and through their leaders as well. As a result, the use of telemedicine has been highly recommended in the wake of the COVID-19 pandemic and even before, especially in improving retention among the PLHIV in care [27] [28]. Our finding supports the findings by Zakumumpa et al. that the COVID-19 pandemic revived interest in community ART delivery models in Uganda, as part of efforts to sustain treatment services among PLHIV. He describes important modifications to and intensified implementation of traditional community drug delivery models such as home-based ART delivery, drug pick-up at Community Drug Distribution Points (CDDPs) and provision of longer treatment refills [29]. This further emphasizes the effectiveness of differentiated service delivery models of HIV care [30] [31] [32], which includes reduced geographic barriers, access to peer support, flexible services, client-centeredness and increased health systems efficiency [30] [33] [34] that are crucial in ensuring favorable HIV treatment outcomes such as viral load suppression, and less likelihood of PLHIV developing drug resistance, which is highly prevalent in Uganda [35] [36]. Similarly, many HIV programs in Western Kenya adopted community approach to HIV care [7] to relieve pressure on the health system and reduce the waiting time for clients who seek HIV treatment services [21] [37] [38]. This is probably the main reason Lodge and Kuchukhidze recommended the scale up of community-based HIV treatment services to mitigate the immense and anticipated disruptions caused by COVID-19 [14].

The study found that youths aged 20 - 24 compared to children aged 0 - 9 years, had higher odds of missing their clinic appointments. Although this study could not find any findings that compared retention among the youths and children younger than 10 years, many reported equally lower retention rates among the groups compared to other age groups. For example, studies from Kenya and Thailand reported that the attrition rate was double among the youths compared to young adolescents aged 10 - 14 years old [39] [40]. This is why it is not surprising that a large study involving PLHIV aged 10 years or older in four SSA countries of Kenya, Mozambique, Rwanda and Tanzania found the highest rates of attrition among the youths when compared with young adolescents [41]. Socioeconomic factors have been described as key barriers to continued engagement in care among the youths. These include geographical (urban vs rural) factors, low social support systems, low income status and non-disclosure of HIV status [41] [42]. It is thus, important for HIV programs to design interventions and services that are youth-friendly in order to maintain them in care.

Unlike several reports from previous studies indicating higher attrition rate among men than women [43] [44] [45] [46], we did not find significant gender differences in burden of missed appointments. However, it is important to note that those studies were conducted nearly a decade ago, yet there have been many interventions to close this gender disparity over the same period [22]. For example, TASO has been implementing differentiated service delivery model of HIV care for more than a decade now [19] and this could have provided men with similar treatment experiences in the clinic.

Furthermore, our study also found that viral load status was associated with the likelihood of attrition. Individuals who had an up-to-date VL status were less likely to miss their appointment compared with those without (P < 0.001). There were no studies found reporting similar findings. However, it could be theorized that PLHIV who attend clinic visits with fidelity are likely to have their VL tests done compared to those who irregularly do so. This position is corroborated by the fact that majority of those without current VL results were in the facility arm (560 vs 320). Hence, this finding concretizes the call for enhanced community interventions for PLHIV.

Finally, clients who received a three- to a six-month’s ART refills seemed less likely to experience missed appointment. Termed as MMD, many policymakers have recommended its use to counter the rampant missed appointments among the PLHIV [17] [22] [34] and improve overall retention in care of clients. Indeed, PLHIV who received ART refills for three months or less were more likely to miss their scheduled appointments than those who were refilled for six months or more (P < 0.001). It can be theorized that clients who received few drug refills have to visit the clinic more frequently, potentially experiencing greater economic costs, especially in the era of COVID-19 pandemic where transport costs are much higher than before compared with those whose appointments were more spaced. MMD ART refills are considered a key component of PLHIV centered care and the President’s Emergency Plan for AIDS Relief (PEPFAR) has consistently recommended its increased uptake to scale to avert the catastrophic impact of COVID-19 on client retention [17] [47]. Therefore, a six-month’s ART refills appears to provide hope in reducing missed appointment schedules among the PLHIV, which could lead to the betterment of these individuals’ engagements in care. Nevertheless, there is a continued call to different HIV programs to ensure continuity of services as the COVID-19 situation continues to terrorize countries [48].

This study used routine program data, which potentially provides a true reflection of the situation on the ground.

The use of secondary data denied us the chance to obtain patient perspective on actual reasons for missing their scheduled appointments. This, therefore, presents an opportunity for a future study to consider this element of the study. Furthermore, this study only focused on one facility which means the findings may not necessarily be representative of the national situation. However, we believe the findings fairly represent the general national picture as all HIV service providers were similarly affected across the country. Also, this study does not describe the impact of the pandemic on patient treatment outcomes such as morbidity, mortality and viral load suppression. Further studies are required involving bigger sample sizes and with longitudinal follow up of clients to provide further information on the long-term impacts of the COVID-19 pandemic on chronic HIV care.

1) The COVID-19 pandemic significantly interrupted HIV care as demonstrated by clients missing their scheduled appointment especially during the peak of COVID-19 pandemic in the country.

2) It was also found that MMD, specifically the six-month’s refills of ART appear to provide better engagement of the PLHIV in care.

3) Community-based PLHIV were less likely to miss their appointment than their facility-based counter-parts.

1) Overall, chronic disease programs should adapt flexible service delivery models to ensure resilience in case of emergency of pandemics that restrict patient physical access to health care facilities. Therefore, different programs need to innovate or adapt strategies in order to mitigate HIV treatment interruptions.

2) There is need to encourage different HIV programs to adopt the MMD because it reduces treatment interruptions. The six-month’s refills particularly sappear to offer more favorable outcomes.

3) Furthermore, more resources need to be directed to retention. Clearly, the pandemic has and most likely, will continue to cause treatment interruptions. Therefore, it is going to be more costly to retain PLHIV in care than before the pandemic.

4) Lastly, it is necessary to adopt community-based HIV services across different age groups. This offers less treatment interruptions, so more focus and resources need to be directed towards community HIV programming. This will require more meaningful involvement of HIV peers which have been demonstrated to be effective elsewhere including in Prevention of Mother to Child Transmission of HIV [49] [50] [51] [52].

We appreciate the USAID RHITES-E mechanism, through INTRAHEALTH and Ministry of Health-Uganda for providing financial and technical guidance to TASO Mbale clinic. We also sincerely thank TASO Uganda senior management and Mr. Gordon Karukomain particular for supporting publication of this study. In addition, Mr. Ceaser Godfrey Mafabi and the entire management team of TASO Mbale is appreciated for their unwavering efforts in supporting TASO Mbale clients and making this study a reality. Finally, we appreciate Mr. Sebastian Jalameso of National Curriculum Development Center (Uganda) for editing this work.

The authors declare no conflicts of interest regarding the publication of this paper.

Oryokot, B., Kazibwe, A., Oluka, A.I., Miya, Y. and Etukoit, M.B. (2021) COVID-19 and HIV Treatment Interruption: A Case Study of the AIDS Support Organization (TASO) Mbale Clinic. World Journal of AIDS, 11, 199-215. https://doi.org/10.4236/wja.2021.114015